Cortes, J., Gambacorti-Passerini, C., Deininger, M., Mauro, M., Chuah, C., Kim, D., … Brümmendorf, T. (2018). Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36(3), 231-237. https://doi.org/10.1200/JCO.2017.74.7162 (Original work published 2018)